Literature DB >> 12099437

Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions.

A Aksozek1, K McClellan, K Howard, J Y Niederkorn, H Alizadeh.   

Abstract

Resistance of Acanthamoeba castellanii cysts to disinfection agents, antimicrobial agents, heat, freeze-thawing, ultraviolet radiation (UV), gamma irradiation, and cellulase were evaluated in vitro. Following exposure to different agents, the cysts were removed and cultured for A. castellanii trophozoites for 3-14 days. Solutions containing 20% isopropyl alcohol or 10% formalin effectively killed A. castellanii cysts. Hydrogen peroxide (3%, AOSept Disinfectant) effectively killed A. castellanii cysts after 4 hr of exposure. Polyhexamethylene biguanide (0.02%), clotrimazole (0.1%), or propamidine isethionate (Brolene) were effective in killing A. castellanii cysts in vitro. Acanthamoeba castellanii cysts were resistant to both 250 K rads of gamma irradiation and 800 mJ/cm2 of UV irradiation. Excystment of trophozoites was accelerated after exposure to 10, 100, and, 1,000 units of cellulase. These results suggest that A. castellanii cysts benefit by enhanced survival because of their resistance to very harsh environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099437     DOI: 10.1645/0022-3395(2002)088[0621:ROACCT]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  39 in total

1.  Long-term, low-maintenance storage of Acanthamoeba strains.

Authors:  Jacob Lorenzo-Morales; Sutherland K Maciver
Journal:  Parasitol Res       Date:  2006-05-19       Impact factor: 2.289

2.  Survival of Acanthamoeba cysts after desiccation for more than 20 years.

Authors:  Rama Sriram; Megan Shoff; Gregory Booton; Paul Fuerst; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

3.  Protozoan Cysts Act as a Survival Niche and Protective Shelter for Foodborne Pathogenic Bacteria.

Authors:  Ellen Lambrecht; Julie Baré; Natascha Chavatte; Wim Bert; Koen Sabbe; Kurt Houf
Journal:  Appl Environ Microbiol       Date:  2015-06-12       Impact factor: 4.792

4.  Acanthamoeba detection in the anterior chamber after therapeutic penetrating keratoplasty.

Authors:  Rk Agarwal; Garima Mittal; Anuradha Raj; Shalini Gupta
Journal:  J Clin Diagn Res       Date:  2014-06-20

5.  Evaluation of Acanthamoeba myosin-IC as a potential therapeutic target.

Authors:  Carmen M Martín-Navarro; Jacob Lorenzo-Morales; Atteneri López-Arencibia; María Reyes-Batlle; José E Piñero; Basilio Valladares; Sutherland K Maciver
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

6.  [Acanthamoeba keratitis].

Authors:  N Szentmáry; L Daas; P Matoula; S Goebels; B Seitz
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

7.  Efficacy of commercial soft contact lens disinfectant solutions against Acanthamoeba.

Authors:  Takeshi Kobayashi; Lindsay Gibbon; Tsuyoshi Mito; Atsushi Shiraishi; Toshihiko Uno; Yuichi Ohashi
Journal:  Jpn J Ophthalmol       Date:  2011-07-12       Impact factor: 2.447

8.  Inhibitory effect of host ocular microenvironmental factors on chlorhexidine digluconate activity.

Authors:  Chun-Hsien Chen; Yu-Jen Wang; Jian-Ming Huang; Fu-Chin Huang; Wei-Chen Lin
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

9.  Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis.

Authors:  Hassan Alizadeh; Sudha Neelam; Michael Hurt; Jerry Y Niederkorn
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

10.  Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.

Authors:  C M Martín-Navarro; A López-Arencibia; F Arnalich-Montiel; B Valladares; J E Piñero; J Lorenzo-Morales
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.